QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 17:03 UTC · Public disclosure record

CFTICKER

Cf Industries Holdings, Inc.

BULLISH stock

Congress has disclosed 13 buys and 9 sells of CF (Cf Industries Holdings, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

13
Buy
9
Sell
+4
Net
10
Active politicians

Round-trip watch Still on the books

Members who disclosed buying CF and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Valerie Hoyle 2024-10-29 $77.84 $123.30 +58.4% in profit
Gilbert Cisneros 2026-01-09 $81.41 $123.30 +51.5% in profit
Alan Armstrong 2026-03-27 $135.20 $123.30 -8.8% underwater

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Chemicals. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
7.46
▼ cheaper than Chemicals (median 23.4)
how it's calculated
P/E = price ÷ earnings per share
$123.30 ÷ $16.52 = 7.46
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
3.25
≈ in line with Chemicals (median 3.6)
how it's calculated
P/B = price ÷ book value per share
$123.30 ÷ $37.98 = 3.25
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
5.36
▼ cheaper than Chemicals (median 17.5)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($18.7B + $3.2B net debt) ÷ $4.1B = $21.9B ÷ $4.1B = 5.36
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

22 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Alan Armstrong Senate BUY ◆ insider divergence · moderate Self 2026-03-27 116 days -9.5% $1K–$15K 82.9 ↗ eFD
Gilbert Cisneros House BUY ◆ insider divergence · moderate Self · 150 Main Street Trust > Bank of America 2026-01-09 33 days +17.3% $1K–$15K
0.1% of NW
13.9 ↗ filing
Julia Letlow House SELL ◆ insider convergence Self · Merrill Lynch Investment Account #025 2025-08-08 24 days +7.7% $1K–$15K
1.0% of NW
32.4 ↗ filing
Valerie Hoyle House BUY ◆ insider divergence Spouse · Fidelity Rollover IRA 2024-10-29 317 days +8.4% $1K–$15K
0.8% of NW
69.5 ↗ filing
Julia Letlow House BUY ◆ insider divergence Self · Merrill Lynch Investment Account #025 2024-10-23 292 days -0.1% $1K–$15K
1.0% of NW
69.8 ↗ filing
Rohit Khanna House BUY OCR Child 2024-07-02 34 days — $1K–$15K 75.9 ↗ filing
Daniel Goldman House SELL Self · Daniel Goldman 12/9/2011 Trust > Aperio Group LLC 2023-03-01 33 days — $1K–$15K
<0.1% of NW
52.4 ↗ filing
Virginia Foxx House SELL Joint 2023-02-16 13 days — $15K–$50K
0.7% of NW
47.4 ↗ filing
Daniel Goldman House SELL Self · Daniel Goldman 1997 Trust > DSG Investment Holdings LLC > TACS 2023-02-03 26 days — $1K–$15K
<0.1% of NW
86.8 ↗ filing
Virginia Foxx House BUY Joint 2022-09-16 0 days — $1K–$15K
0.2% of NW
15.7 ↗ filing
Virginia Foxx House BUY Joint 2022-09-12 0 days — $1K–$15K
0.2% of NW
22.3 ↗ filing
Virginia Foxx House BUY Joint 2022-09-07 0 days — $1K–$15K
0.2% of NW
40.4 ↗ filing
Virginia Foxx House BUY Joint 2022-09-01 0 days — $15K–$50K
0.7% of NW
90.9 ↗ filing
Gilbert Cisneros House SELL Self 2020-04-29 9 days — $1K–$15K
0.1% of NW
40.4 ↗ filing
Gilbert Cisneros House BUY Self 2020-03-18 28 days — $1K–$15K
0.1% of NW
75.9 ↗ filing
Donna Shalala House SELL Self 2019-04-30 0 days — $1K–$15K 40.4 ↗ filing
Donna Shalala House SELL Self 2019-04-16 14 days — $1K–$15K 75.9 ↗ filing
Pete Sessions House SELL Spouse 2018-02-05 1 days — $15K–$50K
0.9% of NW
30.7 ↗ filing
Pete Sessions House BUY Spouse 2017-03-07 0 days — $1K–$15K
0.2% of NW
22.3 ↗ filing
Michael Conaway House SELL Spouse 2016-09-12 3 days — $1K–$15K 75.9 ↗ filing
Pete Sessions House BUY Spouse 2016-07-22 0 days — $1K–$15K
0.2% of NW
40.4 ↗ filing
Pete Sessions House BUY Spouse 2016-05-12 0 days — $15K–$50K
0.9% of NW
90.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in CF — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

1
Congress trades with insider convergence
4
…with insider divergence
62
Insider open-market trades

Of the congressional trades in CF, 1 coincided with corporate insiders moving the same way within 60 days, and 4 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-03-17 Frost Bert A C-suite SELL $756K ↗ EDGAR
2026-03-17 Hoker Richard A Other SELL $439K ↗ EDGAR
2026-03-17 Mayer Erik M. Other SELL $187K ↗ EDGAR
2026-03-13 Will W Anthony Director SELL $4.3M ↗ EDGAR
2026-03-13 Will W Anthony Director SELL $2.7M ↗ EDGAR
2026-03-12 Frost Bert A C-suite SELL $854K ↗ EDGAR
2026-03-12 Menzel Susan L C-suite SELL $2.5M ↗ EDGAR
2026-03-11 Will W Anthony Director SELL $3.4M ↗ EDGAR
2026-03-09 Frost Bert A C-suite SELL 10b5-1 $643K ↗ EDGAR
2026-03-06 Frost Bert A C-suite SELL 10b5-1 $1.2M ↗ EDGAR
2026-03-06 Mayer Erik M. Other SELL $256K ↗ EDGAR
2026-03-06 McGrane Michael Patrick Other SELL $427K ↗ EDGAR
2026-03-05 Dempsey Linda M Other SELL $92K ↗ EDGAR
2026-03-05 Hoker Richard A Other SELL $676K ↗ EDGAR
2026-03-05 Malik Ashraf K Other SELL $271K ↗ EDGAR
2026-03-05 Menzel Susan L C-suite SELL $799K ↗ EDGAR
2026-03-05 Will W Anthony Director SELL $6.3M ↗ EDGAR
2026-03-04 Dempsey Linda M Other SELL $106K ↗ EDGAR
2026-03-04 Dempsey Linda M Other SELL $15K ↗ EDGAR
2026-03-03 McGrane Michael Patrick Other SELL $291K ↗ EDGAR
2026-03-03 Menzel Susan L C-suite SELL $415K ↗ EDGAR
2026-03-03 Will W Anthony Director SELL $3.3M ↗ EDGAR
2026-03-03 Will W Anthony Director SELL $3.7M ↗ EDGAR
2026-03-02 Frost Bert A C-suite SELL 10b5-1 $541K ↗ EDGAR
2026-03-02 Malik Ashraf K Other SELL $890K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
Congress 2026-03-27 Alan Armstrong BUY $1K–$15K
◆ insider 2026-03-17 Frost Bert A C-suite SELL $756K
◆ insider 2026-03-17 Hoker Richard A Other SELL $439K
◆ insider 2026-03-17 Mayer Erik M. Other SELL $187K
◆ insider 2026-03-13 Will W Anthony Director SELL $4.3M
◆ insider 2026-03-13 Will W Anthony Director SELL $2.7M
◆ insider 2026-03-12 Frost Bert A C-suite SELL $854K
◆ insider 2026-03-12 Menzel Susan L C-suite SELL $2.5M
◆ insider 2026-03-11 Will W Anthony Director SELL $3.4M
◆ insider 2026-03-09 Frost Bert A C-suite 10b5-1 SELL $643K
◆ insider 2026-03-06 Frost Bert A C-suite 10b5-1 SELL $1.2M
◆ insider 2026-03-06 Mayer Erik M. Other SELL $256K
◆ insider 2026-03-06 McGrane Michael Patrick Other SELL $427K
◆ insider 2026-03-05 Dempsey Linda M Other SELL $92K
◆ insider 2026-03-05 Hoker Richard A Other SELL $676K
◆ insider 2026-03-05 Malik Ashraf K Other SELL $271K
◆ insider 2026-03-05 Menzel Susan L C-suite SELL $799K
◆ insider 2026-03-05 Will W Anthony Director SELL $6.3M
◆ insider 2026-03-04 Dempsey Linda M Other SELL $106K
◆ insider 2026-03-04 Dempsey Linda M Other SELL $15K
◆ insider 2026-03-03 McGrane Michael Patrick Other SELL $291K
◆ insider 2026-03-03 Menzel Susan L C-suite SELL $415K
◆ insider 2026-03-03 Will W Anthony Director SELL $3.3M
◆ insider 2026-03-03 Will W Anthony Director SELL $3.7M

FAQ Common questions

How much has Congress traded CF?

13 disclosed buys and 9 sells of CF (Cf Industries Holdings, Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade CF?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.